“The Global Epigenetics Market Is Projected to Register a CAGR of 13.5% During the Forecast Period (2017–2022).”

in epigenetic •  7 years ago 

“The Global Epigenetics Market Is Projected to Register a CAGR of 13.5% During the Forecast Period (2017–2022).”

The global epigenetics market is projected to reach USD 1,605.7 million by 2022 from USD 854.0 million in 2017, at a CAGR of 13.5% during the forecast period. The decreasing sequencing costs and time, increasing research activities, favorable funding scenario for epigenetics research, rising prevalence of cancer are the key factors driving market growth during the forecast period. On the other hand, the high cost of instruments is expected to restrain the growth of this market to a certain extent.

Request a Free Sample copy of This Premium Research Report: https://watchersofmarkets.com/collections/marketsandmarkets/products/epigenetics-market-by-product-kit-enzymes-reagent-ngs-mass-spectrometer-pcr-bioinformatics-application-oncology-cardiology-immunology-technology-dna-methylation-histone-modification-end-user-academic-cro-global-forecast-to-2022#tab-questions

“Oncology Segment Dominated the Global Epigenetics Market, by Application, in 2016”
On the basis of application, the epigenetics market is segmented into oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other applications (includes neurology, gynecology, and infectious diseases). In 2016, the oncology segment accounted for the major share of the global epigenetics market. The large share of this segment is attributed to the rising prevalence of cancer and the increasing number of research-related activities.

Read more on this report: https://watchersofmarkets.com/collections/marketsandmarkets/products/epigenetics-market-by-product-kit-enzymes-reagent-ngs-mass-spectrometer-pcr-bioinformatics-application-oncology-cardiology-immunology-technology-dna-methylation-histone-modification-end-user-academic-cro-global-forecast-to-2022

“Pharmaceutical and Biotechnology Companies to Register the Highest Growth Rate During the Forecast Period”
On the basis of end users, the epigenetics market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs). The pharmaceutical and biotechnology companies segment is expected to register the highest CAGRduring the forecast period, owing to increasing research in the areas of genomics with a strong focus on personalized medicine.

“APAC to Witness the Highest Growth Rate During the Forecast Period”
The global epigenetics market is broadly segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa. North America accounted for the largest share of the global epigenetics market in 2016, while Asia Pacific is projected to register the highest growth rate during the forecast period. Factors such as increasing R&D spending, favorable government initiatives, and rising focus of key market players on enhancing their presence in this region are supporting the growth of the epigenetics market in the Asia Pacific.

The breakup of primary participants has been mentioned below:
• By Company Type – Tier 1: 35%, Tier 2–40% and Tier 3–25%
• By Designation – C Level: 33%, Director Level: 41%, Others: 26%
• By Region – North America: 35%, Europe: 30%, Asia Pacific: 21%, and RoW: 14%
The prominent players in the epigenetics market include Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), and Bio-Rad (US).

Research Coverage:
The report analyzes the Epigeneticss market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, therapy, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.
This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the Epigeneticss market. The report analyzes the market based on product, type, therapy, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the Epigeneticss market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various Epigeneticss across regions
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the Epigeneticss market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the Epigeneticss market

Related report:
Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents Enzymes) Application (PCR Sequencing Cloning Epigenetics) End User (Academic & Research Institutes Hospitals & Diagnostic Centers) and Region - Global Forecast to 2024

“The molecular biology enzymes and kits & reagents market projected to grow at a CAGR of 15.8%.”
The global molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 billion by 2022 from USD 6.52 billion in 2017, at a CAGR of 15.8% during the forecast period. The key factors driving the growth of this market include increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases & genetic disorders. However, limited reimbursements for genetic testing is expected to restrain the growth of this market during the forecast period.

Read More:
https://watchersofmarkets.com/products/molecular-biology-enzymes-and-kits-reagents-market-by-product-kits-reagents-enzymes-application-pcr-sequencing-cloning-epigenetics-end-user-academic-research-institutes-hospitals-diagnostic-centers-and-region-global-forecast-to-202

About Us:
We are one of the world's largest market research store bridging you with market research insights, analysis and data from many market research publishers around the globe.
Our experienced market research consultants, from our headquarters (Den Haag, Netherlands) understand client’s research requirements in precise manner and get many proposals on the table suiting your budget and mapping your research goals. Our only motives is to provide clients with precise insights into their respective niche markets; offering them the most comprehensive portfolio of business information products.

Contact:
Watchers of Markets
Henriëtte van der Meydreef 144,2492 JG, Den Haag, Netherlands.
Website:- https://watchersofmarkets.com/
Phone number: +31- 85 888 111 6
Email Id :- [email protected]

Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!